{
    "applicationNumber": "BR 11 2022 010677-7",
    "filingDate": "30/11/2020",
    "grantDate": null,
    "title": "USO DE REBOXETINA PARA TRATAR TRANSTORNOS DO SISTEMA NERVOSO",
    "nationalPhaseDate": [
        "31/05/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/062560",
        "pctDate": "30/11/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/943,077",
            "priorityDate": "03/12/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/946,295",
            "priorityDate": "10/12/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "16/740,329",
            "priorityDate": "10/01/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "16/740,409",
            "priorityDate": "11/01/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "16/740,410",
            "priorityDate": "11/01/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "16/740,411",
            "priorityDate": "11/01/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2683"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2693"
        }
    ],
    "inventors": [
        "HERRIOT TABUTEAU"
    ],
    "holders": [
        246200
    ],
    "ipcCodes": [
        "A61P 25/24",
        "A61K 31/5375"
    ]
}